A new hormonal intrauterine device (IUD) called Liletta has been approved by the U.S. Food and Drug Administration (FDA). Similar to the Mirena IUD, Liletta is inserted into the uterus and releases doses of the hormone levonorgestrel to prevent pregnancy for up to 3 years.
Birth control IUDs such as the Mirena IUD have come under scrutiny after thousands of women experienced severe side effects related to the devices. More than 70,000 women filed Mirena complaints to the FDA after suffering complications, including internal bleeding, pain and tissue damage when the device perforates the uterus.
Liletta will likely be available in the United States in the second quarter of 2015, though it is already available in Europe. Meanwhile, thousands of patients have filed Mirena lawsuits against manufacturer Bayer Pharmaceuticals alleging that the company released an unsafe device.